Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.

Antzeko izenburuak

• Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
  nork: Ndembi, N, et al.
  Argitaratua: (2010)
• Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
  nork: Green, H, et al.
  Argitaratua: (2007)
• Brain antioxidants and hippocampal microanatomical alterations following the administration of Efavirenz/Lamivudine/Tenofovir disoproxil fumarate and Lamivudine/Nevirapine/Zidovudine in adult male Wistar rats
  nork: Innocent A. Edagha, et al.
  Argitaratua: (2022-06-01)
• Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
  nork: Gibb, D, et al.
  Argitaratua: (2002)
• Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
  nork: Yu Cong, et al.
  Argitaratua: (2016-01-01)